Table 2.
Markers of cancer stem cells of the female reproductive system
| Tumor type | Marker | References |
|---|---|---|
|
Ovarian cancer |
SP+ |
Szoket, 2006 [2] |
| Clonogenic cells |
Bapat, 2005 [3] |
|
| CD44+, CD117+ |
Zhang, 2008 [4] |
|
| CD133+ |
Curley, 2009 [5] |
|
| Baba, 2009 [6] | ||
| Ferrandina, 2008 [7] | ||
| Kusumbe, 2009 [9] | ||
| CD44+, MYD88+ |
Alvero, 2009 [8] |
|
|
Uterine cancer |
Clonogenic cells |
Hubbard, 2009 [24] |
| SP+ |
Friel, 2008 [25] |
|
| Kato, 2010 [26] | ||
| Cervical cancer | p63 y CK17 |
eliminated |
| Nanog, Musashi-1, Nucleostemin |
Ye, 2008 [30] |
|
| Spheres, ALDH1, CD44 |
Li, 2011 [33] |
|
| Spheres-CD49f |
Li, 2011 [33] |
|
| Spheres |
López, 2012 [32] |
|
| ALDH1 |
Gu, 2011 [34] |
|
| CD44 |
Abbreviations: CD, Cluster of differentiation, LRC, Label-retaining cell, SP, Side population, PDGF-Rβ, PDGF-receptor β, ALDH, Aldehyde dehydrogenase, MSC, mesenchymal stem cell.